Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Mixed Urinary Incontinence: later-stage trial registry

2 of 3 indexed Mixed Urinary Incontinence trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Mixed Urinary Incontinence: 3 US clinical trials tracked, 2 recruiting.

Mixed Urinary Incontinence is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is InMode MD, running 1 of these trials.

Enrollment posture brief

Registry condition mixed-urinary-incontinence

OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Mixed Urinary Incontinen (th…67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Mixed Urinary Incontinence

Mixed Urinary Incontinence lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mixed Urinary Incontinence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mixed Urinary Incontinence is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Mixed Urinary Incontinence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Saline Injections Drug
1 trials
OnabotulinumtoxinA (Botox ®) Injections Drug
1 trials
Simulated (sham) detrusor nerve radiofrequency ablation Device
1 trials
Detrusor nerve radiofrequency ablation Device
1 trials
Bulkamid Transurethral Bulking Agent Device
1 trials
Solyx Single-incision Sling Device
1 trials

US sites by state

Facility locations filed on Mixed Urinary Incontinence trials. A trial with sites in several states counts in each.

Illinois 3 trials
North Carolina 2 trials
California 2 trials
Texas 1 trials
Rhode Island 1 trials
Pennsylvania 1 trials
Nevada 1 trials
Nebraska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mixed Urinary Incontinence page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Mixed Urinary Incontinence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • InMode MD sponsors the most Mixed Urinary Incontinence trials on record, review their full trial history before evaluating a specific study. See InMode MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mixed Urinary Incontinence condition card totals 3 registered trials; most-linked intervention Saline Injections; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.